Atlas Analytics · FDA findings by region

Region Wise Top Issues: what FDA investigators cite in North America, EMEA, APAC and Latin America

Procedures and process validation are the two most cited issues in FDA inspections of medical device facilities in every region Atlas tracks. In North America they were tagged 1,334 and 1,312 times. For human drug facilities, CAPA, data integrity and procedures lead in North America, APAC and EMEA alike.

Unlock the full dashboard

Atlas issue tags on FDA inspection findings · North America, Latin America, EMEA and APAC · figures read October 14, 2026

AAtlas Analytics/ Region Wise Top IssuesData as of Oct 14, 2026

Region Wise Top Issues

Product type

Devices, Human Drugs

Region

All

More product types

4 more

Country

All

4

Regions compared

1,334

Device procedure findings, North America

80

Device process validation findings, EMEA

169

Drug CAPA findings, North America

Medical devices: North America

  • Procedures1,334
  • Process validation1,312
  • Data integrity890
  • CAPA766
  • Complaints765

5 more issues and the US and Canada split

Unlock

Medical devices: EMEA

  • Process validation80
  • Procedures77
  • Data integrity50
  • CAPA48
  • Complaints47

The country split across EMEA

Unlock

Medical devices: APAC

  • Procedures55
  • Process validation54
  • Data integrity39
  • CAPA36
  • Complaints34

China, India, Japan, Korea and more

Unlock

Human drugs: North America

  • CAPA169
  • Data integrity166
  • Procedures166
  • Process validation166
  • Investigations149

Human drugs in APAC, EMEA and Latin America

Unlock

Biologics, foods, animal products and tobacco by region

In the complete dashboard

The same top-issue view for the four other FDA product categories.

Unlock
Medical DevicesHuman DrugsBiologicsFoodsPage 1 of 4

Complete dashboard

Get the full dashboard for your team

This page shows a free window. Share your work email and our team will send access to the complete dashboard, including:

  • Biologics, foods, animal products and tobacco by region
  • The country split inside each region
  • Top 10 issues per region, not just the top 5
  • Human drugs in Latin America
  • Filters by date range
Book a demo

Top FDA inspection issues for medical devices, by region

The pattern holds across geographies: written procedures, process validation and data integrity sit at the top for device facilities in North America, EMEA and APAC. Corrective and preventive action and complaint handling follow everywhere. Since February 2, 2026 those findings are written against ISO 13485 under the QMSR, covered in our ISO 13485 clause analytics and our guide to the latest FDA regulations for device manufacturers.

Latin America has far fewer device findings in the record, led by process validation and complaints with single-digit counts.

Top 5 issues for medical device inspections by region. Counts are Atlas issue tags on FDA findings.
IssueNorth AmericaEMEAAPAC
Procedures1,3347755
Process validation1,3128054
Data integrity8905039
CAPA7664836
Complaints7654734

Top FDA inspection issues for human drugs, by region

For human drug facilities the top five are closer together. CAPA, data integrity, procedures and process validation are tagged within a few counts of each other in North America and APAC, which suggests investigators cite them together. A weak CAPA system shows up again in our guide to corrective and preventive action.

Top issues for human drug inspections by region. Counts are Atlas issue tags on FDA findings.
IssueNorth AmericaAPACEMEA
CAPA1696715
Data integrity1666715
Procedures1666614
Process validation1666714

Frequently asked questions

What are the most common FDA inspection findings for medical devices?

Across every region Atlas tracks, written procedures and process validation are the most cited device issues, followed by data integrity, CAPA and complaint handling. In North America they were tagged 1,334, 1,312, 890, 766 and 765 times. See what the FDA expects from device manufacturers.

Do FDA findings differ between regions?

The ranking barely changes. Procedures, process validation and data integrity lead in North America, EMEA and APAC for devices, and CAPA and data integrity lead for drugs. What changes is volume: North America carries most findings because most FDA inspections are domestic.

Which regions does the FDA inspect outside the US?

The FDA inspects facilities in Canada, Latin America, Europe, the Middle East, Africa and Asia Pacific. In 2025 the EU, China and India received the most foreign inspections, shown on the US FDA inspections analytics page.

How does Atlas assign an issue to a finding?

Atlas reads each published inspection observation and tags it with one or more topic keywords such as CAPA, data integrity or process validation. A single observation can carry several tags, so counts show how often a topic appears, not the number of inspections. The source observations are in the Form 483 database.

How do I get the full regional data?

Enter your work email in the dashboard above. The full view adds biologics, foods, animal products and tobacco, the country split inside each region and the top 10 issues. Our team reviews each request and replies by email.